[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346228-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346228-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","association-between-proton-pump-inhibitor-use-and-upper-gastrointestinal-cancer-a-matched-case-control-study-accounting-for-reverse-causation-and-confounding-by-indication","Association between proton pump inhibitor use and upper gastrointestinal cancer - A matched case-control study accounting for reverse causation and confounding by indication","","Proton pump inhibitors (PPIs) are widely used for acid-related disorders, yet observational studies have suggested a possible link between long-term PPI use and upper gastrointestinal cancers. Such signals may arise from confounding by indication and reverse causation, distorting causal interpretation. This matched case-control study evaluates the association between PPI exposure and upper GI cancer while explicitly addressing these biases using national Israeli electronic health records.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/association-between-proton-pump-inhibitor-use-and-upper-gastrointestinal-cancer-a-matched-case-control-study-accounting-for-reverse-causation-and-confounding-by-indication/346228/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/association-between-proton-pump-inhibitor-use-and-upper-gastrointestinal-cancer-a-matched-case-control-study-accounting-for-reverse-causation-and-confounding-by-indication/346228.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What bias concerns can affect studies of PPI use and upper GI cancer?","Question",{"text":63,"@type":64},"Confounding by indication and reverse causation can create misleading associations in observational research.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the matched case-control study designed?",{"text":68,"@type":64},"The study used national Israeli electronic health records, with each incident upper GI cancer case matched to multiple cancer-free controls based on age, sex, ethnic sector, socioeconomic status, and enrollment year.",{"name":70,"@type":61,"acceptedAnswer":71},"How was PPI exposure measured in relation to diagnosis time?",{"text":72,"@type":64},"PPI exposure was derived from pharmacy records and modeled in discrete prediagnosis windows: 0–6 months, 6–12 months, 1–3 years, and 3–10 years.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346228,1790923226,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","OPEN ACCESS  \nCitation: Sawaid IO, Din Z, Golan E,  \nRuppin E, Golan-Cohen A, Green I, et al. (2026) Association between proton pump inhibitor use and upper gastrointestinal cancer: A matched case-control study accounting for reverse causation and confounding by indication. PLoS Med 23(1): e1004842. [https://doi.org/10.1371/](https://doi.org/10.1371/)[ ](https://doi.org/10.1371/)[journal.pmed.1004842](journal.pmed.1004842)  \nAcademic Editor: Gilaad G. Kaplan, University of Calgary, CANADA  \nReceived: July 21, 2025  \nAccepted: November 18, 2025  \nPublished: January 6, 2026  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pmed.1004842  \nCopyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon,  \nRESEARCH ARTICLE  \nAssociation between proton pump inhibitor use and upper gastrointestinal cancer: A matched case-control study accounting for reverse causation and confounding by indication  \nIbrahim O. Sawaid1, Zohar Din2, Efrat Golan3, Eytan Ruppin4,5, Avivit Golan-Cohen2,6,  \nIlan Green2,6, Eugene Merzon2,7, Shlomo Vinker2,6, Abraham O. Samson1, Ariel Israel2,8*  \n1 Drug Discovery Lab, Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel, 2 Department of Family Medicine and Leumit Research Institute, Leumit Health Services, Tel-Aviv, Israel, 3 Pediatric Intensive Care Unit, Haemek Medical Center, Afula, Israel, 4 Cancer Data Science Laboratory, National Cancer Institute, Bethesda, Maryland, United States of America, 5 Translational Research Institute and the Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, 6 Department of Family Medicine, Grey Faculty of Medical & Health Sciences, Tel-Aviv University, Tel-Aviv, Israel, 7 Adelson School of Medicine, Ariel University, Ariel, Israel, 8 Department of Epidemiology and Preventive Medicine, Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Tel-Aviv, Israel  \n* [dr.ariel.israel@gmail.com](dr.ariel.israel@gmail.com)  \nAbstract  \nBackground  \nProton pump inhibitors (PPIs) are widely used for acid-related disorders, but observational studies have raised concerns about a possible association between long-term PPI use and upper gastrointestinal (GI) cancers. These associations may reflect confounding by indication and reverse causation. We aimed to evaluate the association between PPI use and upper GI cancer while explicitly addressing these biases.  \nMethods and findings  \nWe conducted a matched case-control study using electronic health records from a national health organization in Israel. Cases were 875 adults (age 63.0 ± 11.9 years, 62.5% male) with incident upper GI cancer (esophageal, gastric, or duodenal) diagnosed between 2003 and 2024; each case was matched to 10 cancer-free controls (n = 8,750) . Matching was performed on age, sex, ethnic sector (general, Jewish ultra-orthodox, and Arab), socioeconomic status, and year of enrollment. PPI exposure was ascertained from pharmacy records and modeled in discrete prediagnosis windows (0–6 months, 6–12 months, 1–3 years, and 3–10 years) . Multivariable conditional logistic regression estimated adjusted odds ratios (aORs) and confidence intervals (CIs), with covariates including age, smoking, body mass index, socioeconomic status, healthcare utilization, pregnancy history (in women), alcohol  \nPLOS Medicine | [https://doi.org/10.1371/journal.pmed.1004842](https://doi.org/10.1371/journal.pmed.1004842) January 6, 2026 1 / 16  \nor otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.  \nData availability stat","cbCaivpn9IUlq95L","https://ap.wps.com/l/cbCaivpn9IUlq95L","pdf",1246070,16,"English","# Abstract\n## Background\n## Methods and findings","[{\"question\":\"What bias concerns can affect studies of PPI use and upper GI cancer?\",\"answer\":\"Confounding by indication and reverse causation can create misleading associations in observational research.\"},{\"question\":\"How was the matched case-control study designed?\",\"answer\":\"The study used national Israeli electronic health records, with each incident upper GI cancer case matched to multiple cancer-free controls based on age, sex, ethnic sector, socioeconomic status, and enrollment year.\"},{\"question\":\"How was PPI exposure measured in relation to diagnosis time?\",\"answer\":\"PPI exposure was derived from pharmacy records and modeled in discrete prediagnosis windows: 0–6 months, 6–12 months, 1–3 years, and 3–10 years.\"}]","Association between proton pump inhibitor use and upper gastrointestinal cancer - A matched case-control study accounting for reverse causation and confounding by indication | PDF",1790060556,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff3fba667a58008407ebb91a37e68264.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df70c37f5c68d7a3854ab564367d5d04.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3eb77c0b18e1df39d9fa4697baa8f6d1.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96ae4b85f59999e07863ab7e52a89455.webp",980,1268]